Veracyte (VCYT) SVP awarded 50,999 shares; some withheld for taxes

Rhea-AI Filing Summary

Veracyte, Inc. reported that SVP and General Counsel Annie McGuire acquired 50,999 shares of common stock through the vesting of performance-based restricted stock units on February 26, 2026. According to the filing, 21,071 PSUs vested on that date, with 29,928 additional PSUs scheduled to vest on December 2, 2026, subject to her continued service.

The filing also notes that 10,867 shares were withheld to cover tax obligations related to the PSU vesting, which is characterized as a tax-withholding disposition rather than an open-market sale. After these transactions, McGuire directly owned 108,266 shares of Veracyte common stock, including 374 shares purchased earlier under the company’s employee stock purchase plan.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider McGuire Annie

Role SVP, General Counsel

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	50,999	$0.00	--
Tax Withholding	Common Stock	10,867	$38.75	$421K

Holdings After Transaction: Common Stock — 119,133 shares (Direct)

Footnotes (1)

1. Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 26, 2026, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein. Of such PSUs, 21,071 PSUs vested on February 26, 2026, and the remaining 29,928 will vest on December 2, 2026, subject to the Reporting Person's continuous service to the Issuer through such date. Includes 374 shares of common stock purchased on January 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McGuire Annie

(Last) (First) (Middle)

6000 SHORELINE COURT, SUITE 300

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/26/2026		A(1)		50,999	A	$0	119,133(2)	D
Common Stock	02/26/2026		F(3)		10,867	D	$38.75	108,266	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 26, 2026, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein. Of such PSUs, 21,071 PSUs vested on February 26, 2026, and the remaining 29,928 will vest on December 2, 2026, subject to the Reporting Person's continuous service to the Issuer through such date.

2. Includes 374 shares of common stock purchased on January 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.

3. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale.

Remarks:

	/s/ Jonathan Wygant, as attorney-in-fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Veracyte (VCYT) report for Annie McGuire?

Veracyte reported that SVP and General Counsel Annie McGuire acquired 50,999 shares of common stock from vesting performance-based restricted stock units. The award reflects achievement of performance goals certified by the board and forms part of her equity-based compensation package.

How many Veracyte (VCYT) PSUs vested and how many remain for Annie McGuire?

The filing states that 21,071 performance-based restricted stock units vested on February 26, 2026. An additional 29,928 PSUs are scheduled to vest on December 2, 2026, contingent on Annie McGuire’s continued service with Veracyte through that date.

Why were 10,867 Veracyte (VCYT) shares disposed of in Annie McGuire’s Form 4?

The 10,867 shares were withheld to satisfy Annie McGuire’s tax withholding obligations related to the PSU vesting. The filing clarifies this represents a tax-withholding disposition of shares, not an open-market sale or discretionary reduction of her investment.

What is Annie McGuire’s Veracyte (VCYT) share ownership after these transactions?

Following the PSU vesting and tax withholding, Annie McGuire directly owned 108,266 Veracyte common shares. This total includes 374 shares previously purchased on January 31, 2026 under the Veracyte Employee Stock Purchase Plan, as noted in the filing.

How are Veracyte (VCYT) performance-based RSUs structured for this award?

These performance-based restricted stock units vest upon certification of performance goal achievement by Veracyte’s board. For Annie McGuire, part vested on February 26, 2026, with the remaining portion scheduled to vest on December 2, 2026, if she remains in continuous service.